Sandu Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 166.07 million compared to INR 167.64 million a year ago. Revenue was INR 166.94 million compared to INR 169.32 million a year ago. Net income was INR 5.51 million compared to INR 5.98 million a year ago. Basic earnings per share from continuing operations was INR 0.57 compared to INR 0.64 a year ago. Diluted earnings per share from continuing operations was INR 0.57 compared to INR 0.64 a year ago.
For the six months, sales was INR 342.64 million compared to INR 329.92 million a year ago. Revenue was INR 343.52 million compared to INR 332.46 million a year ago. Net income was INR 6.6 million compared to INR 7.67 million a year ago. Basic earnings per share from continuing operations was INR 0.68 compared to INR 0.84 a year ago. Diluted earnings per share from continuing operations was INR 0.68 compared to INR 0.84 a year ago.